U.S. Demographic Shift Drives Growth Across Healthcare Stocks and ETFs
Rapid growth in the aging U.S. population is driving increased demand for age-related medical treatments, lifting valuations across biopharma companies and specialized exchange-traded funds. Census and public health data show that adults aged 65 and older accounted for 18.9% of the U.S. population in 2025, representing roughly 64.6 million people, with nearly 80% managing at least one chronic condition.
Major healthcare providers and pharmaceutical companies are expanding their research and product lines to target conditions affecting older adults. Eli Lilly and Company (LLY) formed a $2.75 billion research agreement to discover AI-driven drug candidates for age-related diseases, while AbbVie Inc. (ABBV) and Amgen Inc. (AMGN) provide treatments targeting Parkinson's disease, bone health, and oncology. Medical device manufacturers including Abbott Laboratories (ABT) and Edwards Lifesciences Corporation (EW) are also scaling specialized hardware for cardiac care and chronic condition management.
Investors following sector trends are tracking diversified funds such as the State Street Health Care Select Sector SPDR ETF (XLV), which holds prominent positions in leading pharmaceutical firms. Market participants will watch upcoming clinical developments, including expanded trial data on GLP-1 drug platforms, alongside long-term demographic shifts that project the U.S. senior population to grow significantly through 2030 and 2060.
Key points
- Adults aged 65 and older comprised 18.9% of the U.S. population in 2025, a share projected to reach 23.4% by 2060.
- Eli Lilly and Company entered a $2.75 billion licensing deal in March 2026 to develop AI-discovered drugs for age-related illnesses.
- AbbVie Inc. and Amgen Inc. have seen year-to-date share gains of 20.1% and 26.1%, respectively, driven by therapies for chronic conditions.
- The State Street Health Care Select Sector SPDR ETF holds $44.49 billion in assets under management and has risen 19% over the past year.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
How is the aging U.S. population affecting healthcare stocks?
An expanding senior demographic increases demand for pharmaceuticals, medical devices, and surgical equipment targeting age-related chronic conditions, supporting sustained revenue growth across the healthcare sector.
Which major companies produce treatments for age-related conditions?
Eli Lilly and Company, AbbVie Inc., Amgen Inc., Abbott Laboratories, and Edwards Lifesciences Corporation develop therapies and devices for conditions such as Parkinson's disease, heart disease, and osteoporosis.
What healthcare ETFs offer exposure to senior demographic trends?
Exchange-traded funds providing broad exposure to aging demographic trends include the State Street Health Care Select Sector SPDR ETF, Vanguard Health Care ETF, and Global X Aging Population ETF.